• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Visual prognosis in patients with Behçet's disease receiving colchicine, systemic corticosteroid or cyclosporin.

作者信息

Hayasaka S, Kawamoto K, Noda S, Kodama T

机构信息

Department of Ophthalmology, Shimane Medical University, Izumo, Japan.

出版信息

Ophthalmologica. 1994;208(4):210-3. doi: 10.1159/000310490.

DOI:10.1159/000310490
PMID:7970549
Abstract

We reviewed retrospectively the charts of 36 patients (72 eyes) with Behçet's disease. The visual acuities in 21 patients receiving colchicine (group A) gradually decreased with time. The visual acuities in 9 patients receiving colchicine and systemic corticosteroid (group B) gradually decreased after the onset of the disease and were significantly worse than those in group A 10 and 15 years after onset. The visual acuities in 6 patients receiving colchicine and cyclosporin (group C) gradually decreased, and their visual acuity scores were similar to those in group A.

摘要

相似文献

1
Visual prognosis in patients with Behçet's disease receiving colchicine, systemic corticosteroid or cyclosporin.
Ophthalmologica. 1994;208(4):210-3. doi: 10.1159/000310490.
2
Infliximab monotherapy versus infliximab and colchicine combination therapy in patients with Behçet's disease.英夫利昔单抗单药治疗与英夫利昔单抗和秋水仙碱联合治疗 Behçet 病患者的效果比较。
Ocul Immunol Inflamm. 2012 Jun;20(3):193-7. doi: 10.3109/09273948.2012.665124. Epub 2012 Apr 9.
3
Efficacy of corticosteroids and cyclosporin in the treatment of retinal vasculitis in patients with Behçet's disease.
Adv Exp Med Biol. 2003;528:563-5. doi: 10.1007/0-306-48382-3_114.
4
Could nicotine be beneficial for Behçet's disease?
Clin Rheumatol. 2002 Aug;21(4):341-2. doi: 10.1007/s100670200090.
5
A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab.一例采用人源化抗白细胞介素-6 受体抗体托珠单抗治疗的贝赫切特病。
Mod Rheumatol. 2012 Apr;22(2):298-302. doi: 10.1007/s10165-011-0497-5. Epub 2011 Jul 12.
6
Long-term effects of cyclophosphamide and colchicine treatment in Behçet's disease.环磷酰胺和秋水仙碱治疗白塞病的长期疗效。
Ann Ophthalmol. 1991 Apr;23(4):148-51.
7
Low dose cyclosporin-A therapy in Behçet's disease.低剂量环孢素A治疗白塞病。
J Ocul Pharmacol. 1994 Fall;10(3):553-60. doi: 10.1089/jop.1994.10.553.
8
Cyclosporin-A therapy in severe uveitis of Behçet's disease.环孢素A治疗白塞病严重葡萄膜炎
Acta Ophthalmol Scand. 1998 Feb;76(1):96-9. doi: 10.1034/j.1600-0420.1998.760118.x.
9
Epidemiological features and visual prognosis of Behçet's disease.
Jpn J Ophthalmol. 1999 Jul-Aug;43(4):312-7. doi: 10.1016/s0021-5155(99)00029-5.
10
A case of tuberculous meningoencephalitis in a patient with Behçet's disease.1例白塞病患者合并结核性脑膜脑炎。
Clin Rheumatol. 2006 Feb;25(1):121-2. doi: 10.1007/s10067-005-1135-4. Epub 2005 May 18.

引用本文的文献

1
Update on the therapy of Behçet disease.白塞病治疗的最新进展。
Ther Adv Chronic Dis. 2014 May;5(3):112-34. doi: 10.1177/2040622314523062.
2
Outcome measures used in clinical trials for Behçet syndrome: a systematic review.白塞病临床试验中使用的结局指标:一项系统评价。
J Rheumatol. 2014 Mar;41(3):599-612. doi: 10.3899/jrheum.131249. Epub 2014 Feb 1.
3
Evidence-based practice in Behçet's disease: identifying areas of unmet need for 2014.白塞病的循证医学实践:确定2014年未满足需求的领域。
Orphanet J Rare Dis. 2014 Jan 30;9:16. doi: 10.1186/1750-1172-9-16.
4
Long-term therapy with low dose cyclosporin A in ocular Behçet's disease.低剂量环孢素A治疗眼部白塞病的长期疗效
Doc Ophthalmol. 2002 Nov;105(3):301-12. doi: 10.1023/a:1021227019915.